Anthos Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Anthos Therapeutics's estimated annual revenue is currently $11.3M per year.(i)
  • Anthos Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Anthos Therapeutics has 73 Employees.(i)
  • Anthos Therapeutics grew their employee count by 78% last year.

Anthos Therapeutics's People

NameTitleEmail/Phone
1
Executive Assistant to CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Co-Founder & Chief Operating OfficerReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Executive Assistant to Chief Operating OfficerReveal Email/Phone
7
Chief Human Resources OfficerReveal Email/Phone
8
Chief Technical & Regulatory OfficerReveal Email/Phone
9
VP, Clinical DevelopmentReveal Email/Phone
10
SVP, Technical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Anthos Therapeutics?

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients. Anthos is a formation of Blackstone (NYSE: BX) Life Sciences and Novartis AG (NYSE: NVS), one of the worlds’ leading pharmaceutical companies. The company is led by a world-class executive team highly experienced in the successful development of therapies for cardiovascular disease.

keywords:N/A

N/A

Total Funding

73

Number of Employees

$11.3M

Revenue (est)

78%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.2M736%N/A
#2
$22.6M7316%$55M
#3
$11.2M739%N/A
#4
$9.2M7316%N/A
#5
$10.8M73109%N/A